03.27.2020 New Jersey Urologic Institute, P.A. is excited to announce that we are now offering the opportunity to connect to your physician with the use of Telehealth Virtual Video Visits. These visits are convenient and enable you to have your office visit from the comfort and safety of your own home. A telehealth video visit will protect you from COVID-19, since you can remain safe and quarantined. Insurance companies and Medicare are covering these visits. In order to participate in a Telehealth Visit, you will need a computer with video or a cell phone with a camera. Setup is free. An email will be sent to you with an appointment time and instructions on how to connect to the Telehealth visit. Our staff is ready to help you get scheduled and connected. To setup a Teleheath Virtual Video Visit, please call our office at (973) 963-9091. Please verify with our office PRIOR TO THE TELEHEATH VISIT that your insurance information and paperwork are up to date. All paper work can be downloaded, filled out and signed and is found on the “Patient Info” page found on the home page. It is also important that the office has your correct email address.

02.01.2015 01.31.2019 Dr. Ilan Waldman of the New Jersey Urologic Institute is pleased to announce that his first patients have been treated with the UroLift® System, the first permanent implant to treat symptoms due to urinary outflow obstruction secondary to benign prostatic hyperplasia (BPH) in men 50 years of age or older. Cleared by the U.S. Food and Drug Administration in 2013, the UroLift System is designed to relieve symptoms caused by an enlarged prostate, while preserving sexual function. “Our practice is committed to providing patients with the highest quality, most effective options to address their urology needs,” said Dr. Ilan Waldman. “The UroLift System has an excellent safety profile and provides men suffering from an enlarged prostate a beneficial first-line treatment alternative to drug therapy or more invasive surgery. Importantly, the UroLift System provides fast and meaningful relief from BPH symptoms, improving overall quality of life for our patients.” The UroLift System permanent implants, delivered during a minimally-invasive procedure, act like window curtain tie-backs to hold the lobes of an enlarged prostate open. Patients recover from the procedure quickly, and return to their normal routines with minimal downtime. Data from clinical trials showed that patients receiving UroLift implants reported rapid symptomatic improvement, improved urinary flow rates, and sustained sexual function. Patients also experienced a significant improvement in quality of life. Most common adverse events reported include hematuria, dysuria, micturition urgency, pelvic pain, and urge incontinence. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure. About BPH Treatment More than 500 million aging men worldwide have an enlarged prostate. Medication is often the first line therapy but relief can be inadequate and temporary. Side effects of treatment can include sexual dysfunction, dizziness and headaches, prompting many patients to quit using the drugs. For these patients, the classic alternative is surgery that cuts or ablates prostate tissue to open the blocked urethra. While current surgical options, such as the 'gold standard' surgery, Transurethral Resection of the Prostate (TURP), can be very effective in relieving symptoms, they can also leave patients with permanent side effects such as urinary incontinence, erectile dysfunction and retrograde ejaculation (dry orgasm). About UroLift The UroLift System provides an alternative to tissue removing surgery for the treatment of an enlarged prostate. Performed through the urethra, a urologist uses the UroLift System to push aside the obstructive prostate lobes and positions small, tailored permanent UroLift implants to hold the prostate lobes in the retracted position. This opens the urethra while leaving the prostate intact. Adverse reactions associated with UroLift System treatment were comparable to other minimally invasive surgical therapies as well as standard cystoscopy. The most common adverse events reported during the study included pain or burning with urination, blood in the urine, pelvic pain, urgent need to urinate, and the inability to control urine because of an urgent need to urinate. Most symptoms were mild to moderate in severity and resolved within two to four weeks after the procedure.

02.01.2015 The New Jersey Urologic Institute is awarded AIUM Ultrasound Practice Accreditation! The Ultrasound Practice Accreditation Council of the American Institute of Ultrasound in Medicine is pleased to announce that the New Jersey Urologic Institute has been awarded ultrasound practice accreditation in the area of Urologic Ultrasound. The New Jersey Urologic Institute achieved this recognition by meeting rigorous voluntary guidelines set by the diagnostic ultrasound profession. All facets of the practice were assessed, including the training and qualification of physicians and sonographers; ultrasound equipment maintenance; documentation; storage, and record-keeping practices; policies and procedures to protect patients and staff; quality assurance methods; and the thoroughness, technical quality and interpretation of the sonograms the practice performs. The American Institute of Ultrasound in Medicine is a multidisciplinary medical association of more than 9900 physicians, sonographers, and scientists dedicated to advancing the safe and effective use of ultrasound in medicine through professional and public education, research, development of guidelines, and accreditation. For more information, visit www.aium.org

06.26.2014 The New Jersey Urologic Institute has met all criteria for laboratory Accreditation by COLA, a national healthcare accreditation organization. Accreditation is given only to laboratories that apply rigid standards of quality in day-to-day operations, demonstrate continued accuracy in the performance of proficiency testing, and pass a rigorous on-site laboratory survey. The New Jersey Urologic Institute has earned COLA accreditation as a result of a long-term commitment to provide quality to our patients.